|
1
|
Spina CS: Androgen deprivation therapy and
radiation therapy for prostate cancer: The mechanism underlying
therapeutic synergy. Transl Cancer Res. 7(Suppl 6): S695–S703.
2018. View Article : Google Scholar
|
|
2
|
Harris WP, Mostaghel EA, Nelson PS and
Montgomery B: Androgen deprivation therapy: Progress in
understanding mechanisms of resistance and optimizing androgen
depletion. Nat Clin Pract Urol. 6:76–85. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Duchesne GM, Woo HH, Bassett JK, Bowe SJ,
D'Este C, Frydenberg M, King M, Ledwich L, Loblaw A, Malone S, et
al: Timing of androgen-deprivation therapy in patients with
prostate cancer with a rising PSA [TROG 03.06 and VCOG PR 01-03
(TOAD)]: A randomised, multicentre, non-blinded, phase 3 trial.
Lancet Oncol. 17:727–737. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Barker HE, Paget JT, Khan AA and
Harrington KJ: The tumour microenvironment after radiotherapy:
Mechanisms of resistance and recurrence. Nat Rev Cancer.
15:409–425. 2015. View
Article : Google Scholar : PubMed/NCBI
|
|
5
|
Hamdy FC, Donovan JL, Lane JA, Mason M,
Metcalfe C, Holding P, Davis M, Peters TJ, Turner EL, Martin RM, et
al: 10-year outcomes after monitoring, surgery, or radiotherapy for
localized prostate cancer. N Engl J Med. 375:1415–1424. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Rusthoven CG, Jones BL, Flaig TW, Crawford
ED, Koshy M, Sher DJ, Mahmood U, Chen RC, Chapin BF, Kavanagh BD
and Pugh TJ: Improved survival with prostate radiation in addition
to androgen deprivation therapy for men with newly diagnosed
metastatic prostate cancer. J Clin Oncol. 34:2835–2842. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Horwitz EM, Bae K, Hanks GE, Porter A,
Grignon DJ, Brereton HD, Venkatesan V, Lawton CA, Rosenthal SA,
Sandler HM and Shipley WU: Ten-year follow-up of radiation therapy
oncology group protocol 92-02: A phase III trial of the duration of
elective androgen deprivation in locally advanced prostate cancer.
J Clin Oncol. 26:2497–2504. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Roach M III, Bae K, Speight J, Wolkov HB,
Rubin P, Lee RJ, Lawton C, Valicenti R, Grignon D and Pilepich MV:
Short-term neoadjuvant androgen deprivation therapy and
external-beam radiotherapy for locally advanced prostate cancer:
Long-term results of RTOG 8610. J Clin Oncol. 26:585–591. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
D'Amico AV, Chen MH, Renshaw AA, Loffredo
M and Kantoff PW: Androgen suppression and radiation vs. radiation
alone for prostate cancer: A randomized trial. JAMA. 299:289–295.
2008.PubMed/NCBI
|
|
10
|
Shipley WU, Seiferheld W, Lukka HR, Major
PP, Heney NM, Grignon DJ, Sartor O, Patel MP, Bahary JP, Zietman
AL, et al: Radiation with or without antiandrogen therapy in
recurrent prostate cancer. N Engl J Med. 376:417–428. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Siddiqui ZA and Krauss DJ: Adjuvant
androgen deprivation therapy for prostate cancer treated with
radiation therapy. Transl Androl Urol. 7:378–389. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Milosevic M, Chung P, Parker C, Bristow R,
Toi A, Panzarella T, Warde P, Catton C, Menard C, Bayley A, et al:
Androgen withdrawal in patients reduces prostate cancer hypoxia:
Implications for disease progression and radiation response. Cancer
Res. 67:6022–6025. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Yao M, Rogers L, Suchowerska N, Choe D,
Al-Dabbas MA, Narula RS, Lyons JG, Sved P, Li Z and Dong Q:
Sensitization of prostate cancer to radiation therapy: Molecules
and pathways to target. Radiother Oncol. 128:283–300. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Polkinghorn WR, Parker JS, Lee MX, Kass
EM, Spratt DE, Iaquinta PJ, Arora VK, Yen WF, Cai L, Zheng D, et
al: Androgen receptor signaling regulates DNA repair in prostate
cancers. Cancer Discov. 3:1245–1253. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Kissick HT, Sanda MG, Dunn LK, Pellegrini
KL, On ST, Noel JK and Arredouani MS: Androgens alter T-cell
immunity by inhibiting T-helper 1 differentiation. Proc Natl Acad
Sci USA. 111:9887–9892. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Kalina JL, Neilson DS, Comber AP, Rauw JM,
Alexander AS, Vergidis J and Lum JJ: Immune modulation by androgen
deprivation and radiation therapy: Implications for prostate cancer
immunotherapy. Cancers (Basel). 9. pii: E13. 2017, View Article : Google Scholar
|
|
17
|
Nead KT, Gaskin G, Chester C,
Swisher-McClure S, Dudley JT, Leeper NJ and Shah NH: Androgen
deprivation therapy and future Alzheimer's disease risk. J Clin
Oncol. 34:566–571. 2016. View Article : Google Scholar
|
|
18
|
Evans JR, Zhao S, Daignault S, Sanda MG,
Michalski J, Sandler HM, Kuban DA, Ciezki J, Kaplan ID, Zietman AL,
et al: Patient-reported quality of life after stereotactic body
radiotherapy (SBRT), intensity modulated radiotherapy (IMRT), and
brachytherapy. Radiother Oncol. 116:179–184. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Nelson AM, Gonzalez BD, Jim HS, Cessna JM,
Sutton SK, Small BJ, Fishman MN, Zachariah B and Jacobsen PB:
Characteristics and predictors of fatigue among men receiving
androgen deprivation therapy for prostate cancer: A controlled
comparison. Support Care Cancer. 24:4159–4166. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Holliday EB, Dieckmann NF, McDonald TL,
Hung AY, Thomas CR Jr and Wood LJ: Relationship between fatigue,
sleep quality and inflammatory cytokines during external beam
radiation therapy for prostate cancer: A prospective study.
Radiother Oncol. 118:105–111. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Feng LR, Dickinson K, Kline N and Saligan
LN: Different phenotyping approaches lead to dissimilar biologic
profiles in men with chronic fatigue following radiation therapy. J
Pain Symptom Manage. 52:832–840. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Vichaya EG, Molkentine JM, Vermeer DW,
Walker AK, Feng R, Holder G, Luu K, Mason RM, Saligan L, Heijnen
CJ, et al: Sickness behavior induced by cisplatin chemotherapy and
radiotherapy in a murine head and neck cancer model is associated
with altered mitochondrial gene expression. Behav Brain Res.
297:241–250. 2016. View Article : Google Scholar
|
|
23
|
Hsiao CP and Hoppel C: Analyzing
mitochondrial function in human peripheral blood mononuclear cells.
Anal Biochem. 549:12–20. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Hsiao CP, Daly B and Hoppel C:
Mitochondrial bioenergetics and cancer-related fatigue in patients
with prostate cancer undergoing localized radiation therapy. Oncol
Nurs Forum. 42:E2132015.
|
|
25
|
Toro-Urrego N, Garcia-Segura LM,
Echeverria V and Barreto GE: Testosterone protects mitochondrial
function and regulates neuroglobin expression in astrocytic cells
exposed to glucose deprivation. Front Aging Neurosci. 8:1522016.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Feng LR, Chen MK, Lukkahatai N, Hsiao CP,
Kaushal A, Sechrest L and Saligan LN: Clinical predictors of
fatigue in men with non-metastatic prostate cancer receiving
external beam radiation therapy. Clin J Oncol Nurs. 19:744–750.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Li M, Bertout JA, Ratcliffe SJ, Eckenhoff
MF, Simon MC and Floyd TF: Acute anemia elicits cognitive
dysfunction and evidence of cerebral cellular hypoxia in older rats
with systemic hypertension. Anesthesiology. 113:845–858. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Feng LR, Nguyen Q, Ross A and Saligan LN:
Evaluating the role of mitochondrial function in cancer-related
fatigue. J Vis Exp. 2018. View
Article : Google Scholar :
|
|
29
|
Wolff BS, Renner MA, Springer DA and
Saligan LN: A mouse model of fatigue induced by peripheral
irradiation. J Vis Exp. 2017. View
Article : Google Scholar : PubMed/NCBI
|
|
30
|
Merseburger AS, Hammerer P, Rozet F,
Roumeguère T, Caffo O, da Silva FC and Alcaraz A: Androgen
deprivation therapy in castrate-resistant prostate cancer: How
important is GnRH agonist backbone therapy? World J Urol.
33:1079–1085. 2015. View Article : Google Scholar :
|
|
31
|
Yellen SB, Cella DF, Webster K, Blendowski
C and Kaplan E: Measuring fatigue and other anemia-related symptoms
with the functional assessment of cancer therapy (FACT) measurement
system. J Pain Symptom Manage. 13:63–74. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Cella D, Eton DT, Lai JS, Peterman AH and
Merkel DE: Combining anchor and distribution-based methods to
derive minimal clinically important differences on the functional
assessment of cancer therapy (FACT) anemia and fatigue scales. J
Pain Symptom Manage. 24:547–561. 2002. View Article : Google Scholar
|
|
33
|
Yost KJ, Eton DT, Garcia SF and Cella D:
Minimally important differences were estimated for six
patient-reported outcomes measurement information system-cancer
scales in advanced-stage cancer patients. J Clin Epidemiol.
64:507–516. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Cella D, Yount S, Sorensen M, Chartash E,
Sengupta N and Grober J: Validation of the functional assessment of
chronic illness therapy fatigue scale relative to other
instrumentation in patients with rheumatoid arthritis. J Rheumatol.
32:811–819. 2005.PubMed/NCBI
|
|
35
|
Lydiatt WM, Denman D, McNeilly DP, Puumula
SE and Burke WJ: A randomized, placebo-controlled trial of
citalopram for the prevention of major depression during treatment
for head and neck cancer. Arch Otolaryngol Head Neck Surg.
134:528–535. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Milam JE, Meeske K, Slaughter RI,
Sherman-Bien S, Ritt-Olson A, Kuperberg A, Freyer DR and Hamilton
AS: Cancer-related follow-up care among Hispanic and non-Hispanic
childhood cancer survivors: The project forward study. Cancer.
121:605–613. 2015. View Article : Google Scholar
|
|
37
|
Zimmerman M, Martinez JH, Young D,
Chelminski I and Dalrymple K: Severity classification on the
Hamilton depression rating scale. J Affect Disord. 150:384–388.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
González-Pinto A, Mosquera F, Reed C,
Novick D, Barbeito S, Vega P, Bertsch J, Alberich S and Haro JM:
Validity and reliability of the Hamilton depression rating scale (5
items) for manic and mixed bipolar disorders. J Nerv Ment Dis.
197:682–686. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Ferrucci L, Maggio M, Bandinelli S,
Basaria S, Lauretani F, Ble A, Valenti G, Ershler WB, Guralnik JM
and Longo DL: Low testosterone levels and the risk of anemia in
older men and women. Arch Intern Med. 166:1380–1388. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
40
|
National Research Council (US): Committee
for the Update of the Guide for the Care and Use of Laboratory
Animals. Institute for Laboratory Animal Research (US) and National
Academies Press (US): Guide for the care and use of laboratory
animals. 8th edition. National Academies Press; Washington (DC):
2011
|
|
41
|
van Dam A: Subgroup analysis in burnout:
Relations between fatigue, anxiety, and depression. Front Psychol.
7:902016. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Wolff BS, Raheem SA and Saligan LN:
Comparing passive measures of fatigue-like behavior in mice. Sci
Rep. 8:142382018. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Kurtz P, Schmidt M, Claassen J, Carrera E,
Fernandez L, Badjatia N, Mayer S and Lee K: Anemia is associated
with brain tissue hypoxia and metabolic crisis after severe brain
injury. Crit Care. 13(Suppl 1): P922009. View Article : Google Scholar
|
|
44
|
Gan L, Ma D, Li M, Yang FC, Rogers RS,
Wheatley JL, Koch LG, Britton SL, Thyfault JP, Geiger PC and
Stanford JA: Region-specific differences in bioenergetic proteins
and protein response to acute high fat diet in brains of low and
high capacity runner rats. Neurosci Lett. 674:49–53. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Ding F, Yao J, Rettberg JR, Chen S and
Brinton RD: Early decline in glucose transport and metabolism
precedes shift to ketogenic system in female aging and Alzheimer's
mouse brain: Implication for bioenergetic intervention. PLoS One.
8:e799772013. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Price EA, Mehra R, Holmes TH and Schrier
SL: Anemia in older persons: Etiology and evaluation. Blood Cells
Mol Dis. 46:159–165. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Andrès E, Serraj K, Federici L, Vogel T
and Kaltenbach G: Anemia in elderly patients: New insight into an
old disorder. Geriatr Gerontol Int. 13:519–527. 2013. View Article : Google Scholar
|
|
48
|
Bower JE, Ganz PA, Irwin MR, Kwan L, Breen
EC and Cole SW: Inflammation and behavioral symptoms after breast
cancer treatment: Do fatigue, depression, and sleep disturbance
share a common underlying mechanism. J Clin Oncol. 29:3517–3522.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Dantzer R: Cytokine, sickness behavior,
and depression. Immunol Allergy Clin North Am. 29:247–264. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Dott W, Mistry P, Wright J, Cain K and
Herbert KE: Modulation of mitochondrial bioenergetics in a skeletal
muscle cell line model of mitochondrial toxicity. Redox Biol.
2:224–233. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Karamercan MA, Weiss SL, Villarroel JP,
Guan Y, Werlin E, Figueredo R, Becker LB and Sims C: Can peripheral
blood mononuclear cells be used as a proxy for mitochondrial
dysfunction in vital organs during hemorrhagic shock and
resuscitation? Shock. 40:476–484. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Ashrafi G, Wu Z, Farrell RJ and Ryan TA:
GLUT4 mobilization supports energetic demands of active synapses.
Neuron. 93:606–615. e32017. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Alquier T, Leloup C, Lorsignol A and
Pénicaud L: Translocable glucose transporters in the brain.
Diabetes. 55(Suppl 2): S131–S138. 2006. View Article : Google Scholar
|
|
54
|
Kang I, Chu CT and Kaufman BA: The
mitochondrial transcription factor TFAM in neurodegeneration:
Emerging evidence and mechanisms. FEBS Lett. 592:793–811. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Chandrasekaran K, Anjaneyulu M, Inoue T,
Choi J, Sagi AR, Chen C, Ide T and Russell JW: Mitochondrial
transcription factor A regulation of mitochondrial degeneration in
experimental diabetic neuropathy. Am J Physiol Endocrinol Metab.
309:E132–E141. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Oka S, Leon J, Sakumi K, Ide T, Kang D,
LaFerla FM and Nakabeppu Y: Human mitochondrial transcriptional
factor A breaks the mitochondria-mediated vicious cycle in
Alzheimer's disease. Sci Rep. 6:378892016. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Dutta S and Sengupta P: Men and mice:
Relating their ages. Life Sci. 152:244–248. 2016. View Article : Google Scholar
|
|
58
|
Ragnow S, Hooshdaran MZ, Sanjay K and
Steiner MS: Toremifene prevents prostate cancer in the transgenic
adenocarcinoma of mouse prostate model. Cancer Res. 62:1370–1376.
2002.
|
|
59
|
Wu CT, Chen WC and Chen MF: The response
of prostate cancer to androgen deprivation and irradiation due to
immune modulation. Cancers (Basel). 11. pii: E20. 2018, View Article : Google Scholar
|
|
60
|
Lin TH, Lee SO, Niu Y, Xu D, Liang L, Li
L, Yeh SD, Fujimoto N, Yeh S and Chang C: Differential androgen
deprivation therapies with anti-androgens casodex/bicalutamide or
MDV3100/Enzalutamide versus anti-androgen receptor ASC-J9(R) lead
to promotion versus suppression of prostate cancer metastasis. J
Biol Chem. 288:19359–19369. 2013. View Article : Google Scholar : PubMed/NCBI
|
